Physician profile
Peter Greenberg
NPI 1568552859
$1,101.57
in general payments reported to CMS, 2019-2025
12 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.83 · 2021: $140 · 2022: $247 · 2023: $135 · 2024: $192 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $199.17 | 2024-2025 | Orgovyx |
| Elekta, INC. | $151.20 | 2021-2022 | |
| Ethicon INC. | $147.01 | 2022 | |
| Galvanize Therapeutics, INC | $135.52 | 2025 | Aliya System |
| Blue Earth Diagnostics | $123.30 | 2021-2025 | Posluma |
| Boston Scientific Corporation | $93.65 | 2023 | Ams 700 |
| Novartis Pharmaceuticals Corporation | $85.87 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $61.21 | 2022-2023 | Prolaris |
| Tactile Systems Technology INC | $32.41 | 2020-2025 | Nimbl, Flexitouch Plus |
| Ge Healthcare | $30.46 | 2025 | |
| Telix Pharmaceuticals | $21.38 | 2022 | |
| Siemens Medical Solutions USA, INC. | $20.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.